Insider Stock Trader

Cluster sell RCKT

Cluster sell at Rocket Pharmaceuticals, Inc.: three insiders sell $155,141 of RCKT

Open-market sales between Nov 5 and Nov 13, none marked as part of a 10b5-1 plan.

Three insiders at Rocket Pharmaceuticals, Inc. (RCKT) sold shares on the open market between Nov 5 and Nov 13, a combined $155,141, according to Form 4 filings with the SEC.

Martin Wilson (general counsel) made the largest sale, $127,813 at an average of $2.39 a share. The table below lists who sold, when, and at what price.

Gaurav Shah (CEO) is the latest to report, in a filing on Nov 17. None of these filings marks the sale as made under a Rule 10b5-1 trading plan.

The numbers below are taken from the Form 4 as filed with the SEC.

Who sold when
InsiderRoleTrade dateSharesAvg. priceValueFiling
Martin WilsonGeneral CounselNov 553,389$2.39$127,813App · SEC
Sarbani ChaudhuriOfficerNov 94,872$2.33$11,337App · SEC
Martin WilsonGeneral CounselNov 134,087$2.25$9,196App · SEC
Gaurav ShahCEONov 133,020$2.25$6,795App · SEC
Total$155,141

See more details on these RCKT insider trades

Each row of the table links to its Form 4 on SEC.gov.

See more large insider sales · See the latest cluster buys and sells

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.